216 related articles for article (PubMed ID: 22035541)
1. Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression.
Hurst NJ; Najy AJ; Ustach CV; Movilla L; Kim HR
Biochem J; 2012 Feb; 441(3):909-18. PubMed ID: 22035541
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells.
Ustach CV; Kim HR
Mol Cell Biol; 2005 Jul; 25(14):6279-88. PubMed ID: 15988036
[TBL] [Abstract][Full Text] [Related]
3. The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth.
Ehnman M; Li H; Fredriksson L; Pietras K; Eriksson U
Oncogene; 2009 Jan; 28(4):534-44. PubMed ID: 18997817
[TBL] [Abstract][Full Text] [Related]
4. Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation.
Riehle KJ; Johnson MM; Johansson F; Bauer RL; Hayes BJ; Gilbertson DG; Haran AC; Fausto N; Campbell JS
Biochim Biophys Acta; 2014 Feb; 1842(2):318-25. PubMed ID: 24269585
[TBL] [Abstract][Full Text] [Related]
5. A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer.
Ustach CV; Huang W; Conley-LaComb MK; Lin CY; Che M; Abrams J; Kim HR
Cancer Res; 2010 Dec; 70(23):9631-40. PubMed ID: 21098708
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator.
Fredriksson L; Ehnman M; Fieber C; Eriksson U
J Biol Chem; 2005 Jul; 280(29):26856-62. PubMed ID: 15911618
[TBL] [Abstract][Full Text] [Related]
7. A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression.
Ustach CV; Taube ME; Hurst NJ; Bhagat S; Bonfil RD; Cher ML; Schuger L; Kim HR
Cancer Res; 2004 Mar; 64(5):1722-9. PubMed ID: 14996732
[TBL] [Abstract][Full Text] [Related]
8. Dynamic regulation of platelet-derived growth factor D (PDGF-D) activity and extracellular spatial distribution by matriptase-mediated proteolysis.
Huang W; Kim HR
J Biol Chem; 2015 Apr; 290(14):9162-70. PubMed ID: 25678707
[TBL] [Abstract][Full Text] [Related]
9. Matriptase activation and shedding through PDGF-D-mediated extracellular acidosis.
Najy AJ; Dyson G; Jena BP; Lin CY; Kim HR
Am J Physiol Cell Physiol; 2016 Feb; 310(4):C293-304. PubMed ID: 26157007
[TBL] [Abstract][Full Text] [Related]
10. A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth.
Huang W; Fridman Y; Bonfil RD; Ustach CV; Conley-LaComb MK; Wiesner C; Saliganan A; Cher ML; Kim HR
Oncogene; 2012 Oct; 31(42):4527-35. PubMed ID: 22158043
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways.
Ahmad A; Wang Z; Kong D; Ali R; Ali S; Banerjee S; Sarkar FH
Breast Cancer Res Treat; 2011 Feb; 126(1):15-25. PubMed ID: 20379844
[TBL] [Abstract][Full Text] [Related]
12. Differential tumorigenic potential and matriptase activation between PDGF B versus PDGF D in prostate cancer.
Najy AJ; Won JJ; Movilla LS; Kim HR
Mol Cancer Res; 2012 Aug; 10(8):1087-97. PubMed ID: 22689130
[TBL] [Abstract][Full Text] [Related]
13. Paracrine signalling in colorectal liver metastases involving tumor cell-derived PDGF-C and hepatic stellate cell-derived PAK-2.
Bandapalli OR; Macher-Goeppinger S; Schirmacher P; Brand K
Clin Exp Metastasis; 2012 Jun; 29(5):409-17. PubMed ID: 22362252
[TBL] [Abstract][Full Text] [Related]
14. An oncogenic activity of PDGF-C and its splice variant in human breast cancer.
Bottrell A; Meng YH; Najy AJ; Hurst N; Kim S; Kim CJ; Kim ES; Moon A; Kim EJ; Park SY; Kim HC
Growth Factors; 2019 Aug; 37(3-4):131-145. PubMed ID: 31542979
[TBL] [Abstract][Full Text] [Related]
15. Tissue plasminogen activator is a potent activator of PDGF-CC.
Fredriksson L; Li H; Fieber C; Li X; Eriksson U
EMBO J; 2004 Oct; 23(19):3793-802. PubMed ID: 15372073
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells.
Devarajan E; Song YH; Krishnappa S; Alt E
Int J Cancer; 2012 Sep; 131(5):1023-31. PubMed ID: 22038895
[TBL] [Abstract][Full Text] [Related]
18. Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model.
Xu L; Tong R; Cochran DM; Jain RK
Cancer Res; 2005 Jul; 65(13):5711-9. PubMed ID: 15994946
[TBL] [Abstract][Full Text] [Related]
19. Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts.
Anderberg C; Li H; Fredriksson L; Andrae J; Betsholtz C; Li X; Eriksson U; Pietras K
Cancer Res; 2009 Jan; 69(1):369-78. PubMed ID: 19118022
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
